科研之友
微信
新浪微博
Facebook
分享链接
摘要
<jats:p>The high rates of attrition that occur in drug development are widely regarded as problematic, but the failure of well-designed studies benefits both researchers and healthcare systems by, for example, generating evidence about disease theories and demonstrating the limits of proven drugs. A wider recognition of these benefits will help the biomedical research enterprise to take full advantage of all the information generated during the drug development process.</jats:p>
- 出版日期2015-11-24
- 单位McGill
